lifevantage mindbody glp-1 system 2 Studies Show Strong Results for LifeVantage Corporation Expands MindBody GLP-1

However, after the SELECT trial showed 20% MACE reduction, CMS issued guidance in March 2024 allowing Part D coverage of Wegovy specifically for cardiovascular risk reduction in patients with established CVD and a BMI of 27 or higher

Recommendation: Vital Nutrients suggests taking 1-2 capsules, 1-2 times daily, or as directed by a healthcare practitioner

"Customers are asking for prescribing plus behavior change or lifestyle intervention to be seamless and integrated, such that the first prescription gets written and then there is a direct, seamless, integrated flow directly into a lifestyle intervention behavior change program that has been proven to work

Now do yours